Moderna: FDA postpones RSV vaccine approval [Yahoo! Finance]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Yahoo! Finance
The biopharmaceutical company says that the US Food and Drug Administration (FDA) has postponed the decision to approve the vaccine until the end of May due to administrative constraints. Yahoo Finance's health reporter Anjalee Khemlani breaks down the details. For more expert insight and the latest market action, click here to watch this full episode of Catalysts. This post was written by Angel Smith Video Transcript Moderna shares after, after the company announcing that the FDA has delayed the approval of its RSV vaccine to the end of May. Yahoo finances, Angeli Kelani joining us now with the latest on. That's right guys. So uh the FDA let Moderna know that even though they were supposed to have a decision by this weekend for that RSV vaccine, they're going to have to delay it due to administrative constraints until the end of May. Now this doesn't fully throw the approval process off track. The CDC is still on, on track to get to their portion of the approval p
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Moderna and MSD share encouraging three-year data from trial of melanoma therapy [Yahoo! Finance]Yahoo! Finance
- Noubar Afeyat MIT Commencement: Imagination – And Action! [Forbes]Forbes
- Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsAccesswire
- Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsBusiness Wire
- Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now? [Yahoo! Finance]Yahoo! Finance
MRNA
Earnings
- 5/2/24 - Beat
MRNA
Sec Filings
- 6/3/24 - Form 144
- 6/3/24 - Form 144
- 6/3/24 - Form 144
- MRNA's page on the SEC website